Management of oromandibular dystonia.
D000328:Adult; D000779:Anesthetics, Local / Q000008:administration & dosage; D018726:Anti-Dyskinesia Agents / Q000008:administration & dosage*; D001480:Basal Ganglia Diseases / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage*; D003937:Diagnosis, Differential; D003951:Diagnostic Errors; D020821:Dystonic Disorders / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D005157:Facial Pain / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008334:Mandible / Q000503:physiopathology; D008410:Masticatory Muscles / Q000503:physiopathology*; D009465:Neuromuscular Agents / Q000008:administration & dosage*; D013705:Temporomandibular Joint Disorders / Q000175:diagnosis* / Q000601:surgery
D000779:Anesthetics, Local; D018726:Anti-Dyskinesia Agents; D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A